CNTA CENTESSA PHARMACEUTICALS PLC Capital Structure Changes 8-K Filing 2024 - Loan Agreement Centessa Pharmaceuticals secured a loan agreement for up to $200 million, with an initial $110 million received, to refinance existing debt and support operations, maturing in December 2029.Get access to all SEC 8-K filings of the CENTESSA PHARMACEUTICALS PLC